Contrast Agents and Injectors Market Analysis | United States | 2016-2022 | MedCore

Contrast Agents and Injectors Market Analysis | United States | 2016-2022 | MedCore

0

The U.S. market for contrast agents and injectors includes X-ray and CT agents, MRI agents and ultrasound agents as well as contrast injectors. In 2015, MRI contrast agents represented the largest segment in the contrast agent and injector market. This segment will continue to have the highest market value driven by increasing procedural volumes.

  • Year: 2016
  • Scope: 2012-2022
  • Region: United States
  • Published Date: 9/1/2016
  • Pages: 104
  • Type: MedCore

This market value does not include the contrast injector segment, as it is a capital-based market instead of consumable-based. In 2015, the MRI contrast agent segment comprised the largest portion of this market. Despite having a lower sales volume, the higher ASP of MRI contrast agents compared to X-Ray CT contrast agents, has allowed this segment to increase in market share. Conversely, stagnant unit growth and decreasing ASPs has caused the X-Ray CT contrast agent segment to experience a decline in market share. Ultrasound contrast agents command the highest ASP and will exhibit a gradually increasing market share driven by sales growth.



The "US Market Report Suite for Medical Imaging Devices 2016 - MedSuite" includes analysis on the following companies currently active in this market:
GE Healthcare
Siemens Healthcare
Philips Healthcare
Bayer
Hologic
Toshiba Medical Systems
Others include: Accutome, Agfa Healthcare, Amrad Medical, Analogic, Arcoma-IMIX, Assured Imaging Mobile Mammography, BK Medical, Bracco, C.R. Bard, Canon, Carestream Health, CMR-Naviscan, Cuattro, Del Medical, Digirad, Dilon Technologies, Ellex/Innovative Imaging, Esaote, eZono, Fischer-Giotto, FONAR, Fujifilm, Gamma Medica Inc., Guerbet, Hitachi Medical Systems, iCRco, Imaging Dynamics Company, IMRIS, Konica Minolta, Lakeshore Technologies Inc., Lantheus Medical Imaging, Machnet B.V., Mallinckrodt, MILabs, Mindray, Neusoft Medical Systems, Paradigm, Planmed OY, Quantel Medical, Rayence, Samsung Medison, Shimadzu, SonoCiné, Sonogage, Sonomed Escalon, SonoSite, Spectrum Dynamics Medical, SuperSonic Imagine, SuperSonic Imagine, Swissray, Teleflex, Terason, Tomey, TXR, ViewRay, Zonare, etc.
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link